MORE NATIONAL NEWS
West Virginia News
News from region's first prime-time newscast. You'll find it First On Fox!
FDA advisers unanimously vote to approve next-generation hepatitis C drug from J&J
Reported by: Associated Press
Reported: Thursday, October 24, 2013 3:36 PM EDT
SILVER SPRING, Md.
An experimental hepatitis C drug from Johnson & Johnson has won unanimous support from government experts who say the medication should be approved to treat patients infected with the liver-destroying virus.
The FDA is not required to follow the group's recommendation, though it often does. A decision on the drug is expected next month.
More than 3 million people in the U.S. have hepatitis C, a blood-borne disease that causes liver damage and is blamed for 15,000 deaths a year. J&J is one of a half-dozen companies working to develop more effective treatments for the virus.